ANI Pharmaceuticals, Inc. (ANIP): Price and Financial Metrics

ANI Pharmaceuticals, Inc. (ANIP): $69.13

0.56 (-0.80%)

POWR Rating

Component Grades

Momentum

C

Stability

C

Sentiment

Quality

C

Add ANIP to Watchlist
Sign Up

Industry: Biotech

Industry

F

Ranked

#18 of 365

in industry

ANIP Price/Volume Stats

Current price $69.13 52-week high $70.81
Prev. close $69.69 52-week low $36.99
Day low $69.00 Volume 252,100
Day high $70.05 Avg. volume 136,026
50-day MA $61.27 Dividend yield N/A
200-day MA $57.32 Market Cap 1.46B

ANIP Stock Price Chart Interactive Chart >

ANIP POWR Grades

  • Growth is the dimension where ANIP ranks best; there it ranks ahead of 99.81% of US stocks.
  • The strongest trend for ANIP is in Growth, which has been heading up over the past 26 weeks.
  • ANIP ranks lowest in Momentum; there it ranks in the 6th percentile.

ANIP Stock Summary

  • ANIP's current price/earnings ratio is 97.68, which is higher than 93.59% of US stocks with positive earnings.
  • In terms of twelve month growth in earnings before interest and taxes, ANI PHARMACEUTICALS INC is reporting a growth rate of -166.71%; that's higher than merely 8.09% of US stocks.
  • Revenue growth over the past 12 months for ANI PHARMACEUTICALS INC comes in at 58.75%, a number that bests 92.23% of the US stocks we're tracking.
  • If you're looking for stocks that are quantitatively similar to ANI PHARMACEUTICALS INC, a group of peers worth examining would be ZBH, GMED, MTX, DHX, and GNRC.
  • ANIP's SEC filings can be seen here. And to visit ANI PHARMACEUTICALS INC's official web site, go to www.anipharmaceuticals.com.

ANIP Valuation Summary

  • ANIP's EV/EBIT ratio is 29.1; this is 99.32% higher than that of the median Healthcare stock.
  • ANIP's price/earnings ratio has moved up 108.3 over the prior 243 months.

Below are key valuation metrics over time for ANIP.

Stock Date P/S P/B P/E EV/EBIT
ANIP 2023-12-29 2.5 2.6 95.9 29.1
ANIP 2023-12-28 2.5 2.6 95.3 29.0
ANIP 2023-12-27 2.5 2.6 95.8 29.1
ANIP 2023-12-26 2.5 2.6 96.2 29.2
ANIP 2023-12-22 2.4 2.5 92.9 28.3
ANIP 2023-12-21 2.4 2.5 92.4 28.1

ANIP Growth Metrics

    The 4 year price growth rate now stands at -32%.
  • The 3 year cash and equivalents growth rate now stands at 89.43%.
  • Its 3 year net cashflow from operations growth rate is now at -162.1%.
Over the past 67 months, ANIP's revenue has gone up $138,387,000.

The table below shows ANIP's growth in key financial areas (numbers in millions of US dollars).

Date Revenue Operating Cash Flow Net Income to Common Stock
2022-09-30 283.082 -38.988 -69.197
2022-06-30 251.322 -48.013 -64.638
2022-03-31 226.092 -36.288 -63.414
2021-12-31 216.136 3.322 -42.793
2021-09-30 212.459 9.798 -22.102
2021-06-30 213.377 13.586 -17.221

ANIP's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
  • ANIP has a Quality Grade of D, ranking ahead of 9.89% of graded US stocks.
  • ANIP's asset turnover comes in at 0.453 -- ranking 96th of 682 Pharmaceutical Products stocks.
  • NWBO, CYTR, and NAII are the stocks whose asset turnover ratios are most correlated with ANIP.

The table below shows ANIP's key quality metrics over time.

Period Asset Turnover Gross Margin ROIC
2021-09-30 0.453 0.570 -0.047
2021-06-30 0.457 0.592 -0.029
2021-03-31 0.460 0.600 -0.018
2020-12-31 0.446 0.582 -0.047
2020-09-30 0.427 0.596 -0.063
2020-06-30 0.425 0.619 -0.054

ANIP Price Target

For more insight on analysts targets of ANIP, see our ANIP price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $45.00 Average Broker Recommendation 1.75 (Moderate Buy)

ANI Pharmaceuticals, Inc. (ANIP) Company Bio


ANI Pharmaceuticals is an integrated specialty pharmaceutical company developing, manufacturing, and marketing branded and generic prescription pharmaceuticals. The company was founded in 2004 and is based in Baudette, Minnesota.


ANIP Latest News Stream


Event/Time News Detail
Loading, please wait...

ANIP Latest Social Stream


Loading social stream, please wait...

View Full ANIP Social Stream

Latest ANIP News From Around the Web

Below are the latest news stories about ANI PHARMACEUTICALS INC that investors may wish to consider to help them evaluate ANIP as an investment opportunity.

Investing in ANI Pharmaceuticals (NASDAQ:ANIP) three years ago would have delivered you a 59% gain

ANI Pharmaceuticals, Inc. ( NASDAQ:ANIP ) shareholders have seen the share price descend 23% over the month. But that...

Yahoo | December 7, 2023

ANI Pharmaceuticals to Present at the Piper Sandler 35th Annual Healthcare Conference

BAUDETTE, Minn., Nov. 22, 2023 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (ANI or the Company) (Nasdaq: ANIP) today announced that Nikhil Lalwani, President & CEO, will participate at the Piper Sandler 35th Annual Healthcare Conference in New York City as follows: Date: Tuesday, November 28, 2023 Time:1:00pm – 1:25pm ET Webcast: Click Here To schedule a 1x1 meeting with the Company, please contact [email protected]. The live and archived webcast will be accessible from the Company’s web

Yahoo | November 22, 2023

A Boring Biopharma Can Be a Good Bet

Investors have finally seen some long awaited and much needed breadth within the market rally in recent trading sessions. This strategy provides downside protection of approximately 14% during the five-month option duration.

Yahoo | November 19, 2023

Insider Sell Alert: SVP, CHIEF HR OFFICER Krista Davis Sells Shares of ANI Pharmaceuticals Inc

ANI Pharmaceuticals Inc (NASDAQ:ANIP) has recently witnessed an insider sell that has caught the attention of investors and market analysts.

Yahoo | November 17, 2023

Is ANI Pharmaceuticals, Inc.'s (NASDAQ:ANIP) Stock Price Struggling As A Result Of Its Mixed Financials?

With its stock down 20% over the past week, it is easy to disregard ANI Pharmaceuticals (NASDAQ:ANIP). It is possible...

Yahoo | November 10, 2023

Read More 'ANIP' Stories Here

ANIP Price Returns

1-mo 14.68%
3-mo 25.37%
6-mo 19.07%
1-year 74.88%
3-year 109.87%
5-year -2.00%
YTD 25.37%
2023 37.06%
2022 -12.70%
2021 58.68%
2020 -52.91%
2019 36.98%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!